Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Provincial Health Commission
- National Natural Science Foundation of China
- Zhejiang Province Natural Science Foundation
This publication has 69 references indexed in Scilit:
- Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: A comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastasesOncology Reports, 2005
- Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial CancerCancer Research, 2005
- Mechanisms of platinum drug resistanceTrends in Pharmacological Sciences, 2005
- Cyclooxygenase-1 and -2 in human testicular tumoursEuropean Journal of Cancer, 2003
- Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.2003
- Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.2002
- Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.2002
- The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-κBCarcinogenesis, 2000
- The role of cyclooxygenases in inflammation, cancer, and developmentOncogene, 1999
- Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines.1996